Literature DB >> 4016746

Monoclonal antibodies against a component related to soluble estrogen receptor.

A I Coffer, K M Lewis, A J Brockas, R J King.   

Abstract

Mice were immunized with 1 to 3 micrograms of cytoplasmic estrogen receptor fragment purified from human myometrium by affinity chromatography. Two RE-antibody-secreting clones were detected from one fusion that were capable of precipitating cytosol RE. Monoclonal antibody D5 (subclass IgG1) reacts with an antigen that is related to RE from immunoprecipitation studies but which can be separated from the hormone binding unit. In the presence of anti-mouse serum, D5 precipitates labeled human cytoplasmic RE complexes from breast tumor, fibroid, myometrial, and endometrial preparations but does not react with nuclear RE from human endometrium or cytoplasmic RE from other species tested. Conversely, antibody C3 (Class IgM) precipitates human cytoplasmic RE and nuclear RE complexes as well as labeled cytoplasmic RE from rat and calf uterus and chick oviduct. Neither antibody reacts with progesterone receptor or androgen receptor from human breast tumor, SHBG from human plasma, or rat alpha-fetoprotein. With D5, steroid labeling of cytoplasmic RE at 25 degrees increased the RE immune complex precipitated. D5 precipitates molybdate-stabilized RE from myometrial cytosol when labeled at 25 degrees but not at 4 degrees. C5 precipitates molybdate-stabilized RE whether cytosol was steroid-labeled at 4 degrees or 25 degrees. For D5, optimal precipitation of RE from human breast tumor was observed when cytosol was steroid-labeled at 25 degrees in buffers of pH range 5 to 6. Immunochemical studies indicate that D5 is associated with a Mr 29,000 component in RE-positive cytosols. Electrofocusing and sucrose density gradient analysis confirmed that D5 antigen is a non-hormone-binding component related to cytosolic RE from breast tumor and myometrium.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016746

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Oestrogen receptors in conjunctival malignant melanoma.

Authors:  J C Underwood
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

2.  Purification and characterization of biologically active scatter factor from ras-transformed NIH 3T3 conditioned medium.

Authors:  A Coffer; J Fellows; S Young; D Pappin; D Rahman
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

3.  Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.

Authors:  D R Ciocca; E H Luque
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

4.  Analysis of estrogen receptors in human breast cancer by assays using monoclonal antibodies and by the dextran-coated charcoal method.

Authors:  N Fujino; K Sakamoto; N Shigaki; J Yamashita; M Kimura; M Akagi
Journal:  Jpn J Surg       Date:  1987-09

5.  Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer.

Authors:  S Singh; R Poulsom; N A Wright; M C Sheppard; M J Langman
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

6.  Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis.

Authors:  P J Wirth; V Egilsson; V Gudnason; S Ingvarsson; S S Thorgeirsson
Journal:  Breast Cancer Res Treat       Date:  1987-11       Impact factor: 4.872

7.  Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.

Authors:  R D Whelan; B T Hill
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results.

Authors:  A Di Leo; C Messa; F Russo; G Misciagna; V Guerra; R Taveri; S Leo
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

9.  The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein.

Authors:  M E Mendelsohn; Y Zhu; S O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Immunohistology of oestrogen receptor and D5 antigen in breast cancer: correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay.

Authors:  D D Giri; V J Dangerfield; R Lonsdale; K Rogers; J C Underwood
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.